To further evaluate the anti-leukemia activity of Apatinib in vivo, we established an acute lymphoblastic leukemia xenograft models by intravenous injection of Nalm6 cells into NODscid-IL2Rg−/− (NSI) mice. Here, IL2RG is linked to acute lymphoblastic leukemia.